Skip to content
Introducing The Psychedelic Practitioner, a new publication by Psychedelic Alpha.
  • Insights
  • Data
  • Advisory
  • Careers
  • Feed
  • Contact
Menu
  • Insights
  • Data
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+
Menu
  • Pα+
Search
Join Pα+
  • Sign in
Menu
  • Sign in
Join Pα+
Search
Close this search box.
  • Insights
  • Data
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+
  • Sign in
Menu
  • Insights
  • Data
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+
  • Sign in
Join Pα+
Search
Close this search box.
  • Insights
  • Data
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+
  • Sign in
Menu
  • Insights
  • Data
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+
  • Sign in
Read more about the article Q3’24 Survey: What are Psychedelics Investors Excited About?

Q3’24 Survey: What are Psychedelics Investors Excited About?

  • Post published:November 25, 2024
  • Post category:Analysis/News/Pα+
Read more about the article Psychedelic Investor Survey Q3 2024

Psychedelic Investor Survey Q3 2024

  • Post published:November 19, 2024
  • Post category:Analysis/News
Read more about the article Dispatch From the DEA: DOI and DOC on Trial As Scientists Challenge Psychedelic Scheduling Bid

Dispatch From the DEA: DOI and DOC on Trial As Scientists Challenge Psychedelic Scheduling Bid

  • Post published:November 18, 2024
  • Post category:Analysis/News
Read more about the article Tripping Over Trump: Will the New Administration Embrace Psychedelic Exceptionalism or ‘Just Say No’?

Tripping Over Trump: Will the New Administration Embrace Psychedelic Exceptionalism or ‘Just Say No’?

  • Post published:November 14, 2024
  • Post category:Analysis/News
Read more about the article Question 4 Fails: Massachusetts Says No to State-Regulated Psychedelics Access and Decriminalisation

Question 4 Fails: Massachusetts Says No to State-Regulated Psychedelics Access and Decriminalisation

  • Post published:November 6, 2024
  • Post category:Analysis/News
Read more about the article Psychedelics on the Ballot 2024

Psychedelics on the Ballot 2024

  • Post published:November 4, 2024
  • Post category:Analysis/News
Read more about the article Psychedelics Advocates Urge Yes on Question 4 Amid Last-Minute Debates

Psychedelics Advocates Urge Yes on Question 4 Amid Last-Minute Debates

  • Post published:November 4, 2024
  • Post category:Analysis/News
Read more about the article Bipartisan Momentum or Radical Reform? Insiders Weigh In on the Future of Psychedelic Research and Regulation Under Trump or Harris

Bipartisan Momentum or Radical Reform? Insiders Weigh In on the Future of Psychedelic Research and Regulation Under Trump or Harris

  • Post published:November 4, 2024
  • Post category:Analysis/News/Pα+
Read more about the article Backed by $15m in NIDA Funding, NYU and B.More Team Up to Trial Psilocybin for Opioid Use Disorder

Backed by $15m in NIDA Funding, NYU and B.More Team Up to Trial Psilocybin for Opioid Use Disorder

  • Post published:October 31, 2024
  • Post category:Analysis/News/Pα+
Read more about the article Compass Pathways Pushes Back Phase 3 Readouts, Lays Off 30% of Staff

Compass Pathways Pushes Back Phase 3 Readouts, Lays Off 30% of Staff

  • Post published:October 31, 2024
  • Post category:Analysis/News/Pα+

End of content

No more pages to load

← Newer Posts
Older Posts →

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

  • Insights
  • Jobs
  • Data
  • Subscribe to Pα+
  • Contact

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.

Subscribe to Pα+
  • Psychedelic Alpha © 2025, All Rights Reserved
  • Privacy Policy
  • Terms of Service

Subscribe to Our Free Newsletter

Join Pα+ for Premium Insights

Subscribe Annually ($200)
Subscribe Monthly ($20)
Learn More